Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study

Funda Meric‐Bernstam, Herbert I. Hurwitz, Kanwal P. S. Raghav et al. · The Lancet Oncology · 2019

Cited by 574 works. doi:10.1016/s1470-2045(18)30904-5

Authors

References